Recently, Saito et al. discovered that heat shock transcription factor 4 (HSF4) is elevated in SR RCC cells and the combination of pazopanib with HSF4 knockdown reduced cell proliferation in SR cells[90]. Here, HSF4 is linked to renal cell adenocarcinoma.